tizanidine

Product NDC
76420-885
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tizanidine
Dosage form
TABLET
Route
ORAL
Labeler
Asclemed USA, Inc.
Application
ANDA208187
Marketing category
ANDA
Substance
TIZANIDINE HYDROCHLORIDE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
76420-885-001000 TABLET in 1 BOTTLE (76420-885-00) 2024-12-27NoHistorical
76420-885-01100 TABLET in 1 BOTTLE (76420-885-01) 2024-12-27NoHistorical
76420-885-1110 TABLET in 1 BLISTER PACK (76420-885-11) 2024-12-27NoHistorical
76420-885-1515 TABLET in 1 BOTTLE (76420-885-15) 2024-12-27NoHistorical
76420-885-21150 TABLET in 1 BOTTLE (76420-885-21) 2024-12-27NoHistorical
76420-885-3030 TABLET in 1 BOTTLE (76420-885-30) 2024-12-27NoHistorical
76420-885-6060 TABLET in 1 BOTTLE (76420-885-60) 2024-12-27NoHistorical
76420-885-8810 TABLET in 1 BOTTLE (76420-885-88) 2024-12-27NoHistorical
76420-885-9090 TABLET in 1 BOTTLE (76420-885-90) 2024-12-27NoHistorical
76420-885-9910 BLISTER PACK in 1 CARTON (76420-885-99) / 10 TABLET in 1 BLISTER PACK2024-12-27NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
tizanidineAsclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM2024-12-26HUMAN PRESCRIPTION DRUG LABEL1